The following Financial Services guidance note Produced in partnership with Puesan Lam and Tony Katz of DLA Piper LLP provides comprehensive and up to date legal information covering:
BREXIT: As of exit day (31 January 2020) the UK is no longer an EU Member State. However, in accordance with the Withdrawal Agreement, the UK has entered an implementation period, during which it continues to be subject to EU law. This has an impact on this Practice Note. For further guidance, see Practice Note: The impact of Brexit on the MiFID II regime.
The recast Markets in Financial Instruments Directive 2014/65/EU (MiFID II) and the Markets in Financial Instruments Regulation (EU) 600/2014 (MiFIR) repealed and replaced the Markets in Financial Instruments Directive 2004/39/EC (MiFID).
MiFID II and MiFIR introduced a commodity derivatives position limits and reporting regime which is aimed at preventing market abuse and supporting orderly pricing and settlement conditions by improving transparency and oversight of financial markets. The regime came into force on 3 January 2018.
This note sets out the position reporting requirements under MiFID II, which apply to trading venues, investment firms trading in commodity derivatives, emission allowances, or emission allowance derivatives, and trading venue members. For more information on position limits, see Practice Note: MiFID II—commodity derivatives—position limits. For more information on MiFID II and MiFIR, see Practice Note: MiFID I, MiFID II and MiFIR—essentials.
The position reporting requirements of MiFID II are further specified in Article 83 of
**Trials are provided to all LexisPSL and LexisLibrary content, excluding Practice Compliance, Practice Management and Risk and Compliance, subscription packages are tailored to your specific needs. To discuss trialling these LexisPSL services please email customer service via our online form. Free trials are only available to individuals based in the UK. We may terminate this trial at any time or decide not to give a trial, for any reason. Trial includes one question to LexisAsk during the length of the trial.
To view the latest version of this document and thousands of others like it, sign-in to LexisPSL or register for a free trial.
Existing user? Sign-in
Take a free trial
0330 161 1234
To view our latest legal guidance content,sign-in to Lexis®PSL or register for a free trial.